funding-eu EU Horizon Europe HORIZON-MISS-2027-02 HORIZON-MISS-2027-02-CANCER-03 Anticancer therapy Biophotonics, Imaging, image and data processing Cancer and its biological basis Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes EU — Italia · scadenza 21/09/2027
funding-eu EU Horizon Europe HORIZON-MISS-2027-02 HORIZON-MISS-2027-02-CANCER-02 Anticancer therapy Clinical medicine Digital data Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers EU — Italia · scadenza 21/09/2027
funding-eu EU Horizon Europe HORIZON-MISS-2027-02 HORIZON-MISS-2027-02-CANCER-01 Anticancer therapy Cancer and its biological basis Epigenetics and gene regulation Leveraging functional genomics to reveal novel targets for cancer treatment EU — Italia · scadenza 21/09/2027
funding-eu EU Horizon Europe HORIZON-MISS-2026-02 HORIZON-MISS-2026-02-CANCER-03 Anticancer therapy Diagnostic tools (e.g. genetic, imaging) Haematology Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers EU — Italia · scadenza 15/09/2026
funding-eu EU Horizon Europe HORIZON-HLTH-2026-02 HORIZON-HLTH-2026-02-DISEASE-12 Anticancer therapy Biobanks Biomarkers European Partnership on Rare Diseases (ERDERA) (Phase 2) EU — Italia · scadenza 15/09/2026
